Benzinga | Dec 17, 2021 07:40AM EST

Goldman Sachs Initiates Coverage On Eli Lilly with Neutral Rating, Announces Price Target of $236

Goldman Sachs analyst Chris Shibutani initiates coverage on Eli Lilly (NYSE:LLY) with a Neutral rating and announces Price Target of $236.